Q

Qingdao Baheal Medical Inc
SZSE:301015

Watchlist Manager
Qingdao Baheal Medical Inc
SZSE:301015
Watchlist
Price: 27.18 CNY -1.52%
Market Cap: 14.3B CNY
Have any thoughts about
Qingdao Baheal Medical Inc?
Write Note

Qingdao Baheal Medical Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Qingdao Baheal Medical Inc
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Q
Qingdao Baheal Medical Inc
SZSE:301015
Gross Profit
ÂĄ2.3B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Sinopharm Group Co Ltd
HKEX:1099
Gross Profit
ÂĄ47.2B
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
12%
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Gross Profit
ÂĄ29.8B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
11%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Gross Profit
ÂĄ11.4B
CAGR 3-Years
5%
CAGR 5-Years
7%
CAGR 10-Years
16%
C
China National Medicines Corp Ltd
SSE:600511
Gross Profit
ÂĄ3.7B
CAGR 3-Years
3%
CAGR 5-Years
1%
CAGR 10-Years
16%
Huadong Medicine Co Ltd
SZSE:000963
Gross Profit
ÂĄ13.5B
CAGR 3-Years
10%
CAGR 5-Years
5%
CAGR 10-Years
13%
No Stocks Found

Qingdao Baheal Medical Inc
Glance View

Market Cap
14.3B CNY
Industry
Health Care

Qingdao Baheal Medical, Inc. engages in the provision of marketing services for pharmaceutical product manufacturers. The company is headquartered in Qingdao, Shandong and currently employs 2,396 full-time employees. The company went IPO on 2021-06-30. The firm provides brand operation, wholesale distribution and retail services for pharmaceutical products. Its brand operation services include consumer education, product academic promotion, marketing planning, business contacts, product distribution, flow tracking and supply chain management services. The firm's wholesale distribution business mainly centers on Qingdao and Beijing, and radiates second-level and above hospitals, community clinics and pharmacies in surrounding cities. Its wholesale distribution products include medicines, Chinese herbal medicine pieces, medical equipment, diagnostic reagents, medical consumables, among others. The firm mainly conducts its business within domestic market.

Intrinsic Value
45.79 CNY
Undervaluation 41%
Intrinsic Value
Price
Q

See Also

What is Qingdao Baheal Medical Inc's Gross Profit?
Gross Profit
2.3B CNY

Based on the financial report for Dec 31, 2023, Qingdao Baheal Medical Inc's Gross Profit amounts to 2.3B CNY.

What is Qingdao Baheal Medical Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
14%

Over the last year, the Gross Profit growth was 9%. The average annual Gross Profit growth rates for Qingdao Baheal Medical Inc have been 16% over the past three years , 14% over the past five years .

Back to Top